Carlyle Group Inc. - Q4 2017 holdings

$1.46 Billion is the total value of Carlyle Group Inc.'s 11 reported holdings in Q4 2017. The portfolio turnover from Q3 2017 to Q4 2017 was 21.4% .

 Value Shares↓ Weighting
USAC BuyUSA Compression Partners LP$415,025,000
-0.4%
25,092,196
+0.6%
28.46%
+7.7%
EVA SellEnviva Partners LP$342,919,000
-6.6%
12,402,149
-0.2%
23.52%
+1.0%
WAIR  Wesco Aircraft Hldgs Inc$170,917,000
-21.3%
23,096,8820.0%11.72%
-14.9%
PEGI SellPattern Energy Group Inccl a$157,994,000
-14.6%
7,351,962
-4.2%
10.84%
-7.6%
XBKS  Xenith Bankshares Inc New$143,434,000
+4.1%
4,239,8580.0%9.84%
+12.6%
GOGL  Golden Ocean Group Ltd$88,407,000
+4.0%
10,847,4470.0%6.06%
+12.4%
SFUN  Fang Hldgs Ltdadr$68,677,000
+37.8%
12,307,6910.0%4.71%
+49.0%
CDEV  Centennial Resource Dev Inccl a$31,353,000
+10.2%
1,583,4770.0%2.15%
+19.1%
NDRO SellEnduro Rty Trtr unit$25,787,000
-31.1%
8,186,486
-4.8%
1.77%
-25.4%
SQBG  Sequential Brnds Group Inc N$11,338,000
-40.5%
6,369,8120.0%0.78%
-35.6%
CIEIQ  Cobalt Intl Energy Inc$2,147,000
-35.3%
2,321,5250.0%0.15%
-30.3%
WFTIQ ExitWeatherford Intl Plc$0-1,000,000
-100.0%
-0.29%
SPNV ExitSuperior Energy Svcs Inc$0-914,934
-100.0%
-0.62%
CCM ExitConcord Med Svcs Hldgs Ltdspon adr cl a$0-4,362,117
-100.0%
-0.97%
Other managers

Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):

Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2018-02-14
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
Wesco Aircraft Hldgs Inc28Q4 201916.8%
Seacor Marine Hldgs Inc22Q3 20231.1%
Enviva Partners LP21Q2 202031.5%
Enduro Rty Tr21Q1 20182.8%
USA Compression Partners LP20Q2 201828.5%
Pattern Energy Group Inc20Q3 201816.2%
Concord Med Svcs Hldgs Ltd19Q3 20171.1%
Superior Energy Svcs Inc19Q3 20170.7%
Cobalt Intl Energy Inc17Q1 201711.0%
Sequential Brnds Group Inc N17Q1 20201.7%

View Carlyle Group Inc.'s complete holdings history.

Latest significant ownerships (13-D/G)
Carlyle Group Inc. Q4 2017 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
Complete Solaria, Inc.September 22, 20232,745,8795.7%
Carlyle Credit Income FundSeptember 14, 20234,785,62841.0%
eFFECTOR Therapeutics, Inc.August 18, 20234,829,8917.8%
Vera Therapeutics, Inc.August 02, 20231,872,7644.2%
Reneo Pharmaceuticals, Inc.May 09, 20232,730,4578.2%
EXICURE, INC.April 13, 2023287,1373.4%
SPRUCE BIOSCIENCES, INC.February 23, 20233,734,5189.2%
Vaxcyte, Inc.February 10, 20232,070,7242.6%
NuCana plcAugust 11, 20223,353,1346.4%
QuidelOrtho CorpJune 06, 202212,460,18318.6%

View Carlyle Group Inc.'s complete significant-ownership history.

Latest filings
TypeFiled
ARS2024-04-18
DEF 14A2024-04-18
DEFA14A2024-04-18
8-K2024-04-03
PRE 14A2024-04-03
42024-04-02
SC 13G2024-03-29
8-K2024-03-27
42024-03-05
SC 13D/A2024-03-05

View Carlyle Group Inc.'s complete filings history.

Compare quarters

Export Carlyle Group Inc.'s holdings